Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ABSI


Fundamental

Company: Absci Corp
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: Small
Index: RUT
P/E: -
EPS (ttm): -0.83
Insider Own: 13.56%
Shs Outstand: 155.35M
Perf Week: 19.92%
Market Cap: 919.84M
Forward P/E: -
EPS next Y: -0.72
Insider Trans: 0.81%
Shs Float: 134.76M
Perf Month: 100.00%
Enterprise Value: 798.56M
PEG: -
EPS next Q: -0.20
Inst Own: 66.44%
Short Float: 26.04%
Perf Quarter: 118.92%
Income: -118.44M
P/S: 499.91
EPS this Y: 8.18%
Inst Trans: 17.60%
Short Ratio: 8.39
Perf Half Y: 54.86%
Sales: 1.84M
P/B: 5.33
EPS next Y Percentage: 6.43%
ROA: -55.34%
Short Interest: 35.09M
Perf YTD: 69.05%
Book/sh: 1.11
P/C: 7.32
EPS next 5Y: 17.45%
ROE: -63.89%
52W High: 6.24 -5.37%
Perf Year: 110.71%
Cash/sh: 0.81
P/FCF: -
EPS past 3/5Y: 9.99% -9.45%
ROIC: -68.02%
52W Low: 2.24 163.39%
Perf 3Y: 315.49%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -21.31% -10.14%
Gross Margin: -520.81%
Volatility W: 14.18%
Volatility M: 10.66%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 434.00
EPS Y/Y TTM: 10.39%
Oper. Margin: -7000.82%
ATR (14): 0.46
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 6.59
Sales Y/Y TTM: -61.87%
Profit Margin: -6450.76%
RSI (14): 78.95
Recom: 1.40
Dividend Gr. 3/5Y: - -
Current Ratio: 6.59
EPS Q/Q: 8.60%
SMA20: 32.94%
Beta: 2.39
Target Price: 8.53
Payout: -
Debt/Eq: 0.03
Sales Q/Q: -81.76%
SMA50: 71.10%
Rel Volume: 1.77
Prev Close: 5.75
Employees: 140
LT Debt/Eq: 0.01
Earnings: May 07 AMC
SMA200: 81.45%
Avg Volume: 4.18M
Price: 5.90
IPO: Jul 22, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: 5.00% -84.52%
Trades:
Volume: 7,338,983
Change: 2.61%

Technical:


Latest News:

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbSci (ABSI) and ... neutral
ABSI AMGN

Summary: Analysts weigh in on AbSci (ABSI) and Amgen (AMGN) in the Healthcare sector with price targets and ratings provided.

Full article
2024-05-20T15:43:14Z